Surveillance of bacterial resistance in Anhui Tongling area during 2012
- VernacularTitle:安徽省铜陵地区2012年细菌耐药性监测
- Author:
Zhiyong SHEN
;
Youliang SONG
;
Qian WANG
;
Xiaolong PAN
;
Dongsheng ZHOU
;
Li HUANG
;
Zeping QIAN
;
Sanbao LIU
;
Ziwu CHEN
;
Xiangyang ZHU
- Publication Type:Journal Article
- Keywords:
bacterium;
antibiotic resistance;
antimicrobial agent
- From:
Chinese Journal of Infection and Chemotherapy
2014;(4):310-315
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the bacterial resistance of clinical isolates collected in Tongling area. Methods Antimicrobial susceptibility test was conducted by Kirby-Bauer method.All the data were analyzed with WHONET 5.5 software.Results A total of 3 092 clinical isolates were collected during 2012,of which gram negative organisms and gram positive organisms accounted for 76.3% (2 359/3 092)and 23.7% (773/3 092),respectively.MRSA and MRCNS accounted for 50.9% of S.aureus and 73.0% of coagulase negative Staphylococcus,respectively.MRSA and MRCNS showed higher resistance to gentamicin,ciprofloxacin and erythromycin.No vancomycin-or teicoplanin-resistant strains of Staphylococcus spp.were found.No vancomycin-or teicoplanin-resistant strains of E.faecalis were found.Some E.faecium strains were resistant to vancomycin and teicoplanin.About 52.1% of E.coli isolates and 42.1% of Klebsiella isolates produced extended-spectrumβ-lactamases (ESBLs).Imipenem-or meropenem-resistant strains of K. pneumoniae were found. The percentage of P.aeruginosa strains resistant to amikacin, cefoperazone-sulbactam and cefepime was 3.4%,14.0% and 17.7%,respectively.More than 70% of Acinetobacter spp. strains were resistant to all the antibiotics tested except minocycline and cefoperazone-sulbactam,to which 42.1%and 4.4% of the strains were resistant.Conclusions The antibiotic resistance of clinical bacterial isolates is growing. The spread of multi-drug or pan-drug resistant strains in a specific region poses a serious threat to clinical practice.We should pay more attention to resistance surveillance and the rational use of antibiotics.
